Evidence map›Paper›PMID 40535097›Full record

ArticleOncology letters2025

Diagnostic and therapeutic understanding of multiple foci hepatic epithelioid haemangioendothelioma: A case report.

Jiang-Wei Mou, Ze-Liang Zhang, Bo Peng, Sheng Wu, Ye Zheng, Ke-Xiang Zhu

Abstract readCase Reports
In one paragraph

Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiang-Wei MouThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
Ze-Liang ZhangThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
Bo PengThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
Sheng WuThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
Ye ZhengThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
Ke-Xiang ZhuThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, low-grade malignant liver tumour. Due to the small number of reported cases and available literature, the understanding of this condition has remained limited. Surgical resection is an important treatment option that substantially prolongs patient survival. This case report discusses a 23-year-old male patient diagnosed with HEHE who presented with multiple tumours, including nine lesions distributed across six different segments of the liver. Prior to surgery, the anatomical locations of the lesions in relation to the liver vasculature were mapped using three-dimensional liver reconstruction. Intraoperative ultrasound (IOUS) was performed to ensure the complete excision of all lesions. At three months post-surgery, follow-up imaging revealed abnormally enhanced nodules in the S4 segment of the liver, which were considered new lesions. After consultation with a multidisciplinary team, the new liver lesions were treated with microwave ablation (MWA) following a puncture biopsy. Given the lack of standardised treatment guidelines for HEHE, this case illustrates the clinical manifestations, laboratory test results and imaging features of multifocal HEHE. Furthermore, it underscores the application of techniques including three-dimensional reconstruction, IOUS and MWA in building diagnostic and therapeutic experiences for HEHE, providing a clinical basis and reference for standardised management in the future.

Indexed as

follow-uphepatectomyhepatic epithelioid hemangioendotheliomamicrowave ablationthree-dimensional reconstruction

Identifiers

PMID40535097
PMCPMC12174752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.